|
MRS2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.722400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.858600E-01 |
| Normal-vs-Stage2 |
4.360400E-01 |
| Normal-vs-Stage3 |
7.018400E-01 |
| Normal-vs-Stage4 |
2.915600E-01 |
| Stage1-vs-Stage2 |
3.171200E-01 |
| Stage1-vs-Stage3 |
6.247800E-01 |
| Stage1-vs-Stage4 |
5.236800E-01 |
| Stage2-vs-Stage3 |
7.570200E-01 |
| Stage2-vs-Stage4 |
2.633400E-01 |
| Stage3-vs-Stage4 |
3.057600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.706200E-01 |
| Normal-vs-AfricanAmerican |
2.076600E-01 |
| Normal-vs-Asian |
8.886400E-01 |
| Caucasian-vs-AfricanAmerican |
1.147200E-01 |
| Caucasian-vs-Asian |
9.308000E-01 |
| AfricanAmerican-vs-Asian |
5.622800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.663400E-01 |
| Normal-vs-Female |
2.526600E-01 |
| Male-vs-Female |
1.118960E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.839000E-01 |
| Normal-vs-Extreme_Weight |
1.992240E-01 |
| Normal-vs-Obese |
8.969400E-01 |
| Normal-vs-Extreme_Obese |
2.169600E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.191000E-01 |
| Normal_Weight-vs-Obese |
8.224200E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.875000E-01 |
| Extreme_Weight-vs-Obese |
4.394600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.370990E-01 |
| Obese-vs-Extreme_Obese |
9.711500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.739400E-01 |
| Normal-vs-Age(41-60Yrs) |
8.629400E-01 |
| Normal-vs-Age(61-80Yrs) |
7.634000E-01 |
| Normal-vs-Age(81-100Yrs) |
6.463900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.753000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.297600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.295800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.870200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.295550E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.510000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.832600E-01 |
| Normal-VS-Type2 PRCC |
8.776600E-01 |
| Normal-VS-KIRP CIMP |
6.802400E-02 |
| Normal-VS-Unclassified PRCC |
7.892600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.862400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.247500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.119000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.618150E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.430800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.078580E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.454400E-01 |
| Normal-vs-N1 |
7.743000E-01 |
| Normal-vs-N2 |
4.38489999998737E-06 |
| N0-vs-N1 |
4.048000E-01 |
| N0-vs-N2 |
4.137500E-02 |
| N1-vs-N2 |
8.167900E-02 |
|
|
